ICU · Infection / pharmacology
Antivirals — Aciclovir, Oseltamivir & the Anti-COVID Agents
Also known as Antiviral · Aciclovir · Acyclovir · Valaciclovir · Ganciclovir · Valganciclovir · Foscarnet · Cidofovir · Oseltamivir · Tamiflu · Zanamivir · Peramivir · Baloxavir · Neuraminidase inhibitor · Remdesivir · Paxlovid · Nirmatrelvir · Molnupiravir · Ribavirin · Antiretroviral · ART
The antivirals in the ICU target the specific viral enzymes. The five ICU-relevant groups: the anti-herpes (the aciclovir — the HSV and the VZV; the DNA polymerase via the thymidine kinase; the NEPHROtoxicity crystal — the hydrate; the HSV encephalitis 10 mg per kg TDS for the 14 to 21 days; the ganciclovir the CMV with the bone-marrow; the foscarnet or the cidofovir the resistant with the nephrotoxic), the anti-CMV (the ganciclovir / the valganciclovir first-line for the transplant and the immunocompromised; the foscarnet and the cidofovir for the resistant or the leucopenic), the anti-influenza (the oseltamivir — the neuraminidase inhibitor; the influenza A and B; the within 48 h of the onset, the severe regardless; the reduces the duration and the complications; the prophylaxis; the zanamivir inhaled, the peramivir IV, the baloxavir the cap-dependent endonuclease), the anti-SARS-CoV-2 (the remdesivir — the RNA polymerase, the severe COVID; the Paxlovid — the nirmatrelvir or the ritonavir protease inhibitor, the early high-risk; the molnupiravir), and the anti-HIV / the ART (the combination antiretroviral therapy — the two NRTIs plus an integrase inhibitor; the ICU the drug-interaction burden, the lactic acidosis, the IRIS, the abacavir hypersensitivity). The renal dosing the critical (the aciclovir, the ganciclovir, the oseltamivir all renally cleared).
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Meet the patient
A 64-year-old man reaches the ED in mid-winter, febrile and unrousable, a day after a flu-like prodrome, and he has a witnessed focal seizure. His GCS is 8, his temperature is 39.1 °C, and he is intubated for airway protection. The differential is wide — but two viral diagnoses are time-critical and will not wait for a PCR: HSV encephalitis and influenza pneumonia.[1]
So without delay you hang empiric aciclovir 10 mg/kg 8-hourly (the regimen randomised in the Swedish encephalitis trial, started on clinical suspicion alone) and give oseltamivir 75 mg via the NG tube twice daily (the standard adult dose used across the oseltamivir trials), alongside broad antibacterials and the septic workup.[15][24] Muthuri's individual-patient meta-analysis advocates early neuraminidase inhibitor treatment in hospitalised adults with suspected or proven influenza — which means not waiting for the PCR — and mortality benefit is greatest within 48 h of symptom onset but extends to later treatment.[6] Hold that first hour in your head — it is the spine of everything that follows.
References43ShowHide
- [1]Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ Vidarabine versus acyclovir therapy in herpes simplex encephalitis N Engl J Med, 1986.PMID 3001520
- [2]Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med, 1993.PMID 8380242
- [3]Martin DF, Sierra-Madero J, Walmsley S, et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis N Engl J Med, 2002.PMID 11948271
- [4]Lalezari JP, Holland GN, Kramer F, et al. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS J Acquir Immune Defic Syndr Hum Retrovirol, 1998.PMID 9525435
- [5]Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group JAMA, 2000.PMID 10697061
- [6]Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data Lancet Respir Med, 2014.PMID 24815805
- [7]Dobson J, Whitley RJ, Pocock S, Monto AS Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials Lancet, 2015.PMID 25640810
- [8]Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents N Engl J Med, 2018.PMID 30184455
- [9]Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Final Report N Engl J Med, 2020.PMID 32445440
- [10]WHO Solidarity Trial Consortium Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Lancet, 2022.PMID 35512728
- [11]Hammond J, Leister-Tebbe H, Gardner A, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 N Engl J Med, 2022.PMID 35172054
- [12]Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients N Engl J Med, 2022.PMID 34914868
- [13]Jabs DA, Ahuja A, Van Natta M, et al. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy Ophthalmology, 2013.PMID 23419804
- [14]Nguyen-Van-Tam JS, Venkatesan S, Muthuri SG, Myles PR Neuraminidase inhibitors: who, when, where? Clin Microbiol Infect, 2015.PMID 25703253
- [15]Sköldenberg B, Forsgren M Acyclovir versus vidarabine in herpes simplex encephalitis Scand J Infect Dis Suppl, 1985.PMID 3912977
- [16]Lakeman FD, Whitley RJ Diagnosis of herpes simplex encephalitis: application of the polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease J Infect Dis, 1995.PMID 7706811
- [17]Soul-Lawton J, Seaber E, On N, Wootton R, Rolan P, Posner J Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans Antimicrob Agents Chemother, 1995.PMID 8593015
- [18]Höglund M, Ljungman P, Weller S Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients J Antimicrob Chemother, 2001.PMID 11389118
- [19]Sawyer MH, Webb DE, Balow JE, Straus SE Acyclovir-induced renal failure. Clinical course and histology Am J Med, 1988.PMID 3376977
- [20]AK AK, Bhutta BS, Mendez MD Herpes Simplex Encephalitis StatPearls, 2026.PMID 32491575
- [21]Hardy WD Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial Am J Med, 1992.PMID 1531285
- [22]Sommadossi JP, Bevan R, Ling T, Lee F, Mastre B, Chaplin MD, Nerenberg C, Koretz S, Buhles WC Jr Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function Rev Infect Dis, 1988.PMID 2847287
- [23]Kiser TH, Fish DN, Zamora MR Evaluation of valganciclovir pharmacokinetics in lung transplant recipients J Heart Lung Transplant, 2012.PMID 22305377
- [24]Kohno S, Kida H, Mizuguchi M, Shimada J Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection Antimicrob Agents Chemother, 2011.PMID 21825298
- [25]Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections N Engl J Med, 1997.PMID 9302301
- [26]Williamson JC, Pegram PS Neuraminidase inhibitors in patients with underlying airways disease Am J Respir Med, 2002.PMID 14720062
- [27]Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 N Engl J Med, 2020.PMID 32459919
- [28]Török ME, Yen NT, Chau TT, Mai NT, Phu NH, Mai PP, Dung NT, Chau NV, Bang ND, Tien NA, Minh NH, Hien NQ, Thai PV, Dong DT, Anh DT, Thoa NT, Hai NN, Lan NN, Lan NT, Quy HT, Dung NH, Hien TT, Chinh NT, Simmons CP, de Jong M, Wolbers M, Farrar JJ Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis Clin Infect Dis, 2011.PMID 21596680
- [29]Abassi M, Boulware DR, Rhein J Cryptococcal Meningitis: Diagnosis and Management Update Curr Trop Med Rep, 2015.PMID 26279970
- [30]Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, Ravinetto R, van Loen H, Nair A, Jackson A, Colebunders R, Maartens G, Wilkinson RJ, Lynen L; PredART Trial Team Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS N Engl J Med, 2018.PMID 30428290
- [31]Meintjes G, Brust JCM, Nuttall J, Maartens G Management of active tuberculosis in adults with HIV Lancet HIV, 2019.PMID 31272663
- [32]LiverTox — National Institute of Diabetes and Digestive and Kidney Diseases Nucleoside Analogues LiverTox [Internet], 2012.PMID 31644243
- [33]Morales-Suárez-Varela M, Peraita-Costa I, Llopis-Morales A, Llopis-González A Influenza Vaccination During Pregnancy: A Narrative Review on Maternal and Neonatal Outcomes Associated with Seasonal Influenza Infection Vaccines, 2026.PMID 42506630
- [34]Avery RK, Arav-Boger R, Marr KA, Kraus E, Shoham S, Lees L, Trollinger B, Shah P, Ambinder R, Neofytos D, Ostrander D, Forman M, Valsamakis A Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection Transplantation, 2016.PMID 27495775
- [35]Fernández S, Castro P, Azoulay E What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients Intensive Care Med, 2025.PMID 39774866
- [36]Onuigbo MA, Nye D, Iloanya PC Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients Adv Perit Dial, 2009.PMID 19886325
- [37]Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza Clin Infect Dis, 2019.PMID 30566567
- [38]Muthuka JK Jr, Nyamai EM, Oluoch K, Maibvise C, Nabaweesi R Paradoxical and Unmasking HIV Immune Reconstitution Inflammation Syndrome in Antiretroviral-Naïve Pregnant Women: A Prospective Cohort Study Cureus, 2024.PMID 38406047
- [39]Yip AJW, Low ZY, Chow VTK, Lal SK Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity Viruses, 2022.PMID 35746815
- [40]Ruttmann E, Geltner C, Bucher B, Ulmer H, Höfer D, Hangler HB, Semsroth S, Margreiter R, Laufer G, Müller LC Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation Transplantation, 2006.PMID 16732179
- [41]Campbell L, Barbini B, Cromarty B, Hamzah L, Williams D, Winston A, Post FA; FANTA trial team Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil AIDS, 2024.PMID 38932750
- [42]Chamberlain CE, Penzak SR, Alfaro RM, Wesley R, Daniels CE, Hale D, Kirk AD, Mannon RB Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients Am J Transplant, 2008.PMID 18444933
- [43]Whitley RJ Herpes simplex encephalitis: adolescents and adults Antiviral Res, 2006.PMID 16675036